Literature DB >> 27214580

Optimizing safety and accuracy of prostate biopsy.

Tonye A Jones1, Jan Phillip Radtke, Boris Hadaschik, Leonard S Marks.   

Abstract

PURPOSE OF REVIEW: The objective of this article is to examine the safety of prostate biopsy and discuss the emerging role of MRI-ultrasound fusion technology in improving diagnostic accuracy. RECENT
FINDINGS: Men undergoing prostate biopsy frequently experience minor complications, including hematospermia, hematuria, and infection. Quinolone-resistant bacteria are a growing concern; thus, transperineal access or modification of antibiotic prophylaxis based on local antibiograms is now used to avoid infectious complications.Multiparametric MRI allows visualization of many prostate cancers, and by fusing MRI with real-time ultrasound, a biopsy needle can be directed by a urologist into suspicious regions of interest. Using this new method, detection of clinically significant prostate cancer has increased and the incidence of falsely negative biopsies has decreased.
SUMMARY: Prostate biopsy is generally a safe procedure, and with attention to local patterns of antibiotic resistance, infectious complications can be minimized. MRI-ultrasound fusion has significantly improved the accuracy of prostate biopsy, allowing tracking and targeting not previously possible.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27214580      PMCID: PMC5011431          DOI: 10.1097/MOU.0000000000000310

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  54 in total

1.  A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.

Authors:  Boris A Hadaschik; Timur H Kuru; Corina Tulea; Philip Rieker; Ionel V Popeneciu; Tobias Simpfendörfer; Johannes Huber; Pawel Zogal; Dogu Teber; Sascha Pahernik; Matthias Roethke; Patrik Zamecnik; Wilfried Roth; Georgios Sakas; Heinz-Peter Schlemmer; Markus Hohenfellner
Journal:  J Urol       Date:  2011-10-19       Impact factor: 7.450

2.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

Review 3.  Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

Authors:  Jeremy P Grummet; Mahesha Weerakoon; Sean Huang; Nathan Lawrentschuk; Mark Frydenberg; Daniel A Moon; Mary O'Reilly; Declan Murphy
Journal:  BJU Int       Date:  2014-02-19       Impact factor: 5.588

4.  Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Authors:  Michael A Liss; Stephen A Taylor; Deepak Batura; Deborah Steensels; Methee Chayakulkeeree; Charlotte Soenens; G Gopal Rao; Atreya Dash; Samuel Park; Nishant Patel; Jason Woo; Michelle McDonald; Unwanaobong Nseyo; Pooya Banapour; Stephen Unterberg; Thomas E Ahlering; Hendrik Van Poppel; Kyoko Sakamoto; Joshua Fierer; Peter C Black
Journal:  J Urol       Date:  2014-06-10       Impact factor: 7.450

5.  Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.

Authors:  Christopher P Filson; Shyam Natarajan; Daniel J A Margolis; Jiaoti Huang; Patricia Lieu; Frederick J Dorey; Robert E Reiter; Leonard S Marks
Journal:  Cancer       Date:  2016-01-07       Impact factor: 6.860

6.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

7.  Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically.

Authors:  Mark Louie-Johnsun; Mischel Neill; Karien Treurnicht; Michael Jarmulowicz; Christopher Eden
Journal:  BJU Int       Date:  2009-05-07       Impact factor: 5.588

8.  Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.

Authors:  Majdi N Al-Hasan; Brian D Lahr; Jeanette E Eckel-Passow; Larry M Baddour
Journal:  J Antimicrob Chemother       Date:  2009-05-12       Impact factor: 5.790

9.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

10.  Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

Authors:  G L Shaw; B C Thomas; S N Dawson; G Srivastava; S L Vowler; V J Gnanapragasam; N C Shah; A Y Warren; D E Neal
Journal:  Br J Cancer       Date:  2014-04-10       Impact factor: 7.640

View more
  4 in total

1.  CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experience.

Authors:  Michael C Olson; Thomas D Atwell; Lance A Mynderse; Bernard F King; Timothy Welch; Ajit H Goenka
Journal:  Eur Radiol       Date:  2016-12-14       Impact factor: 5.315

2.  Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy.

Authors:  Rebecca S Steinberg; Lauren Kipling; K C Biebighauser Bens; Dattatraya Patil; Mark Henry; Akanksha Mehta; Christopher Filson
Journal:  World J Urol       Date:  2021-03-26       Impact factor: 3.661

3.  Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing.

Authors:  Naveen Ramesh; Emi Sei; Pei Ching Tsai; Shanshan Bai; Yuehui Zhao; Patricia Troncoso; Paul G Corn; Christopher Logothetis; Amado J Zurita; Nicholas E Navin
Journal:  Genome Biol       Date:  2020-07-06       Impact factor: 13.583

4.  A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion.

Authors:  Pegah Khosravi; Maria Lysandrou; Mahmoud Eljalby; Qianzi Li; Ehsan Kazemi; Pantelis Zisimopoulos; Alexandros Sigaras; Matthew Brendel; Josue Barnes; Camir Ricketts; Dmitry Meleshko; Andy Yat; Timothy D McClure; Brian D Robinson; Andrea Sboner; Olivier Elemento; Bilal Chughtai; Iman Hajirasouliha
Journal:  J Magn Reson Imaging       Date:  2021-03-14       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.